Whalesbook
So, hua kya ki April 16th ko Nippon India Mutual Fund aur Theleme India Master Fund ne milkar 2.26% equity khareed li. Iske baad stock 7.74% bhaag kar ₹878.6 par pahunch gaya. Pichhle ek mahine se stock ek range mein tha, phir yeh buying hui.
Nippon India ne 13.82 lakh shares (yani 1.76% stake) khareede ₹111.95 Crore mein, aur Theleme India Fund ne 4 lakh shares (0.5% stake) liye ₹32.4 Crore mein. Dono ne average ₹810 per share ke hisaab se kharida. Lekin saath hi saath, promoters — Rahul Pradeep Rathi, Pradeep Ramwilas Rathi, aur Anuj Narayandas Rathi ne milkar 3% holdings bechi, jisse ₹191.09 Crore mile. Yeh bhi lagbhag ₹810 ke rate par hi tha. Toh, ek taraf buying, doosri taraf selling — market mein confusion toh hai hi!
Ab company ka background dekhte hain. Yeh dyes aur pigments banati hai, aur is sector mein growth toh acchi dikh rahi hai, khaas kar textiles aur automotive se demand aa rahi hai. Analysts bhi generally positive hain aur inka average target price ₹1,218.67 hai. Lekin, yahan ek bada twist hai: company ka trailing P/E ratio negative mein hai, jabki industry ka average 38.76 hai. Negative P/E matlab recent mein profit mein problems ho sakti hain, aur ROE bhi sirf 3-8% hai. Pichhle ek saal mein toh stock -23.8% gir bhi gaya hai.
Aur ek badi khabar yeh hai ki Sudarshan Chemical Germany ki Heubach group ke global pigment business ko €127.5 million (yani lagbhag ₹1,180 Crore) mein acquire kar rahi hai. Yeh deal agar successful hui toh company ka global footprint aur product range kaafi badh jayega.
Par bhai, numbers thode alag keh rahe hain. December 2025 quarter mein revenue 3% gir kar ₹648 Crore ho gaya aur EBITDA bhi 3% gir kar ₹77 Crore raha. Profit Before Tax 8% gir kar ₹33 Crore tha. Company ne per share ₹9.35 ka net loss report kiya hai, aur trailing EPS bhi negative -5.26 hai. Promoter selling shayad isi wajah se ho rahi ho, ya phir debt manage karne ke liye. Uske upar, itni badi Heubach acquisition ko integrate karna bhi ek risk hai, jab company khud hi financial pressure mein ho aur ROE kam ho.
Toh overall scenario kya hai? Analysts ko lagta hai ki Heubach deal aur market position ki wajah se stock mein potential hai aur target price ₹1,218.67 tak ja sakta hai. Lekin shareholders ko abhi current earnings problems, acquisition integration aur promoter selling ko bhi dhyan mein rakhna hoga. Dekhna yeh hai ki yeh institutional confidence, promoter caution aur company ke numbers aage kaise play out karte hain.